2002, Blood Pressure and DEA - Medical Cannabis Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2002

Blood Pressure

DEA

Chacruna: Ayahuasca FOIA Requests Reveal Increased Ayahuasca Seizures, Lack of Due Process and Government Secrecy

Cannabis Law Report

JUNE 28, 2021

Drug Enforcement Agency (“DEA”). CBP did disclose a “Seized Asset Management and Enforcement Procedures Handbook,” dated January 2002, that it said explains the CBP policies related to seizing and destroying controlled substances like ayahuasca. Drug Enforcement Administration (DEA). Customs Border Patrol (“CBP”) and U.S.

DEA

DEA Blood Pressure Safety Policy

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

JULY 12, 2019

28) Side effects noted included strangely enough, vomiting and abdominal pain, psychiatric side effects including depression and paranoia, and low blood pressure. 2002 Jun;42(8):993-1007. 32: United States DEA. 27) A 1998 study found a low potential for abuse and no indication of patients chasing the drug. (28)

Extraction

Extraction Pharmaceutical CBD Epilepsy

Chacruna: Ayahuasca FOIA Requests Reveal Increased Ayahuasca Seizures, Lack of Due Process and Government Secrecy

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Stay Connected